SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Jan-24 9:55 PM View: | Vera Therapeutics, Inc. (VERA) | 10-Jan-24 | Sale | 1,050,000 | $18.00 | $18,900,000.00 | (19%) 5.45M to 4.4M | |
09-Aug-23 4:10 PM View: | Vistagen Therapeutics, Inc. (VTGN) | 07-Aug-23 | Purchase | 775,756 | $23.15 | $17,961,100.00 | 97% 799.24K to 1.57M | |
22-Jun-23 4:10 PM View: | Vera Therapeutics, Inc. (VERA) | 20-Jun-23 | Private Purchase | 448,217 | $15.17 | $6,799,000.00 | 9% 5.0M to 5.45M | |
27-Feb-23 5:14 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Acquisition (other) | 729,891 | -- | -- | 102% 718.13K to 1.45M | |
27-Feb-23 5:14 PM View: | Enliven Therapeutics, Inc. (ELVN) | 23-Feb-23 | Purchase | 622 | $22.07 | $13,723.30 | < 1% 1.45M to 1.45M | |
23-Feb-23 4:05 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Feb-23 | Purchase | 23,565 | $5.11 | $120,488.00 | < 1% 2.85M to 2.87M | |
23-Feb-23 4:05 PM View: | Enliven Therapeutics, Inc. (ELVN) | 21-Feb-23 | Purchase | 8,194 | $5.25 | $43,010.30 | < 1% 2.84M to 2.85M | |
16-Nov-22 4:05 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 14-Nov-22 | Sale | 3,250,000 | $0.71 | $2,294,500.00 | (88%) 3.71M to 461.29K | |
29-Nov-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 24-Nov-21 | Market Purchase | 2,922 | $5.42 | $15,837.20 | < 1% 3.71M to 3.71M | (3%) |
23-Nov-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 22-Nov-21 | Market Purchase | 9,979 | $5.49 | $54,784.70 | < 1% 3.7M to 3.71M | < 1% |
23-Nov-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 19-Nov-21 | Market Purchase | 3,225 | $5.44 | $17,544.00 | < 1% 3.7M to 3.7M | 2% |
12-Nov-21 4:31 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 11-Nov-21 | Market Purchase | 7,941 | $6.05 | $48,043.10 | < 1% 3.69M to 3.7M | 1% |
12-Nov-21 4:31 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 10-Nov-21 | Market Purchase | 9,622 | $5.85 | $56,288.70 | < 1% 3.68M to 3.69M | 5% |
10-Nov-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 08-Nov-21 | Market Purchase | 560 | $5.99 | $3,354.40 | < 1% 3.68M to 3.68M | 4% |
08-Nov-21 4:33 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 05-Nov-21 | Market Purchase | 7,800 | $5.95 | $46,410.00 | < 1% 3.67M to 3.68M | 2% |
08-Nov-21 4:33 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 04-Nov-21 | Market Purchase | 1,400 | $5.88 | $8,232.00 | < 1% 3.67M to 3.67M | 3% |
04-Nov-21 4:31 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 02-Nov-21 | Market Purchase | 8,880 | $5.64 | $50,083.20 | < 1% 3.66M to 3.67M | 8% |
02-Nov-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 29-Oct-21 | Market Purchase | 44,651 | $5.71 | $254,957.00 | 1% 3.61M to 3.66M | 6% |
29-Oct-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 28-Oct-21 | Market Purchase | 15,082 | $5.55 | $83,705.10 | < 1% 3.6M to 3.61M | < 1% |
29-Oct-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 27-Oct-21 | Market Purchase | 39,581 | $5.45 | $215,716.00 | 1% 3.56M to 3.6M | 3% |
25-Oct-21 4:31 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 22-Oct-21 | Market Purchase | 27,629 | $5.51 | $152,236.00 | < 1% 3.53M to 3.56M | 2% |
25-Oct-21 4:31 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 21-Oct-21 | Market Purchase | 32,816 | $5.40 | $177,206.00 | < 1% 3.5M to 3.53M | 4% |
21-Oct-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 20-Oct-21 | Market Purchase | 40,663 | $5.44 | $221,207.00 | 1% 3.46M to 3.5M | 1% |
21-Oct-21 4:30 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 19-Oct-21 | Market Purchase | 87,580 | $5.07 | $444,031.00 | 3% 3.37M to 3.46M | 8% |
19-Oct-21 5:13 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 18-Oct-21 | Market Purchase | 36,194 | $4.87 | $176,265.00 | 1% 3.33M to 3.37M | 2% |
19-Oct-21 5:13 PM View: | Satsuma Pharmaceuticals, Inc. (STSA) | 15-Oct-21 | Market Purchase | 126,000 | $4.83 | $608,580.00 | 4% 3.21M to 3.33M | 3% |